Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald R Dunbar

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
European Heart Journal|November 20, 2012
Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics StudyEls Wauters, Kathryn F Carruthers, Ian Buysschaert, et al.
European Heart Journal|September 1, 2010
Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)Keith A A Fox, Kathryn F Carruthers, Donald R Dunbar, et al.
Plos One|September 15, 2011
A stratified transcriptomics analysis of polygenic fat and lean mouse adipose tissues identifies novel candidate obesity genesNicholas M Morton, Yvonne B Nelson, Zoi Michailidou, et al.
European Heart Journal|March 17, 2010
A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics StudyIan Buysschaert, Kathryn F Carruthers, Donald R Dunbar, et al.
The Journal of Biological Chemistry|March 25, 2009
Angiotensin-converting enzyme is a modifier of hypertensive end organ damageXiaojun Liu, Christopher O C Bellamy, Matthew A Bailey, et al.
Lipids in Health and Disease|August 11, 2015
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Lipids in Health and Disease|August 3, 2016
Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Diabetes|February 26, 2011
Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient miceMalgorzata Wamil, Jenny H Battle, Sophie Turban, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2012
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosisPrakash Ramachandran, Antonella Pellicoro, Madeleine A Vernon, et al.
Nature Medicine|October 31, 2023
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver diseaseTimothy J Kendall, Maria Jimenez-Ramos, Frances Turner, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
European Heart Journal|November 20, 2012
Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics StudyEls Wauters, Kathryn F Carruthers, Ian Buysschaert, et al.
European Heart Journal|September 1, 2010
Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)Keith A A Fox, Kathryn F Carruthers, Donald R Dunbar, et al.
Plos One|September 15, 2011
A stratified transcriptomics analysis of polygenic fat and lean mouse adipose tissues identifies novel candidate obesity genesNicholas M Morton, Yvonne B Nelson, Zoi Michailidou, et al.
European Heart Journal|March 17, 2010
A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics StudyIan Buysschaert, Kathryn F Carruthers, Donald R Dunbar, et al.
The Journal of Biological Chemistry|March 25, 2009
Angiotensin-converting enzyme is a modifier of hypertensive end organ damageXiaojun Liu, Christopher O C Bellamy, Matthew A Bailey, et al.
Lipids in Health and Disease|August 11, 2015
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Lipids in Health and Disease|August 3, 2016
Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?Emily N W Yeung, Philipp Treskes, Sarah F Martin, et al.
Diabetes|February 26, 2011
Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient miceMalgorzata Wamil, Jenny H Battle, Sophie Turban, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2012
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosisPrakash Ramachandran, Antonella Pellicoro, Madeleine A Vernon, et al.
Nature Medicine|October 31, 2023
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver diseaseTimothy J Kendall, Maria Jimenez-Ramos, Frances Turner, et al.
Pageof 4